G.K. Abou-Alfa

681 citations
30 papers · 467 indexed · h-index 11
Topics
Hepatocellular Carcinoma Treatment and Prognosis (18 papers)Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers)Pancreatic and Hepatic Oncology Research (7 papers)

In The Last Decade

G.K. Abou-Alfa

27 papers receiving 454 citations

Peers

G.K. Abou-Alfa
Comparison fields: 5 of 42
  • Hepatology 266
  • Oncology 179
  • Cancer Research 127
  • Surgery 114
  • Molecular Biology 108
Replace Silvia Bozzarelli with:
Silvia Bozzarelli Italy
Hilda Wong China
Guoliang Shao China
Diyang Xie China
Amani Asnacios France
Kevin Perraud Switzerland
Judit Peix Spain
Neus Llarch Spain
Osamu Okochi Japan
Chengyou Du China
G.K. Abou-Alfa relative to Silvia Bozzarelli Italy Silvia Bozzarelli's profile →
Citations per field
00.5×1.5×
Silvia Bozzarelli · 1×
Citations per year

Countries citing papers authored by G.K. Abou-Alfa

Since Specialization
Citations

This map shows the geographic impact of G.K. Abou-Alfa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G.K. Abou-Alfa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G.K. Abou-Alfa more than expected).

Fields of papers citing papers by G.K. Abou-Alfa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G.K. Abou-Alfa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G.K. Abou-Alfa. The network helps show where G.K. Abou-Alfa may publish in the future.

Co-authorship network of co-authors of G.K. Abou-Alfa

This figure shows the co-authorship network connecting the top 25 collaborators of G.K. Abou-Alfa. A scholar is included among the top collaborators of G.K. Abou-Alfa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G.K. Abou-Alfa. G.K. Abou-Alfa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 16
2 14
3 5
4 12
5 2
6 6
7 4
8 21
9 6
10 3
11 9
12
A young woman with liver cancer
1
13 1
14 0
15 45
16 1
17 1
18 152
19 41
20 53

About G.K. Abou-Alfa

G.K. Abou-Alfa is a scholar working on Hepatology, Oncology and Cancer Research, having authored 30 papers that have together received 467 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (18 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers) and Pancreatic and Hepatic Oncology Research (7 papers). The work is most often cited by research in Hepatology (266 citations), Cancer Research (127 citations) and Oncology (179 citations). G.K. Abou-Alfa has collaborated with scholars based in United States, France and South Korea. Frequent co-authors include Yuman Fong, Kui Hin Liau, Ronald P. DeMatteo, Michael I. D’Angelica, Leslie H. Blumgart, Francesco Stipa, William R. Jarnagin, Sam S. Yoon, E. M. O' Reilly and Robert L. De Jager. Their work appears in journals such as Journal of Clinical Oncology, Cancer and Annals of Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026